Avantor (NYSE:AVTR – Get Free Report) is anticipated to announce its Q3 2025 results before the market opens on Wednesday, October 29th. Analysts expect Avantor to post earnings of $0.23 per share and revenue of $1.6475 billion for the quarter. Investors can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Wednesday, October 29, 2025 at 8:00 AM ET.
Avantor (NYSE:AVTR – Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). Avantor had a net margin of 10.31% and a return on equity of 11.39%. The firm had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the prior year, the firm earned $0.25 earnings per share. The company’s revenue was down 1.1% on a year-over-year basis. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Avantor Price Performance
Shares of NYSE:AVTR opened at $15.44 on Monday. The firm has a market capitalization of $10.52 billion, a PE ratio of 15.59, a PEG ratio of 5.03 and a beta of 0.98. The company has a current ratio of 0.98, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. Avantor has a 1-year low of $10.82 and a 1-year high of $23.70. The business’s 50 day moving average is $13.33 and its 200-day moving average is $13.34.
Insider Activity
Hedge Funds Weigh In On Avantor
Large investors have recently modified their holdings of the stock. Osaic Holdings Inc. boosted its holdings in shares of Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after acquiring an additional 1,189 shares during the last quarter. Daiwa Securities Group Inc. grew its position in shares of Avantor by 3.0% during the 2nd quarter. Daiwa Securities Group Inc. now owns 81,172 shares of the company’s stock valued at $1,093,000 after acquiring an additional 2,344 shares during the period. Strategic Wealth Investment Group LLC purchased a new stake in shares of Avantor during the 2nd quarter worth approximately $32,000. Finally, Tower Research Capital LLC TRC raised its holdings in shares of Avantor by 13.8% in the 2nd quarter. Tower Research Capital LLC TRC now owns 20,001 shares of the company’s stock worth $269,000 after purchasing an additional 2,421 shares during the period. 95.08% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
AVTR has been the subject of a number of recent research reports. Evercore ISI dropped their price objective on shares of Avantor from $18.00 to $16.00 and set an “outperform” rating for the company in a research note on Monday, August 4th. Stifel Nicolaus set a $12.00 price target on shares of Avantor and gave the stock a “hold” rating in a research note on Monday, August 4th. Wells Fargo & Company lowered their price objective on Avantor from $19.00 to $16.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Royal Bank Of Canada cut their target price on Avantor from $20.00 to $17.00 and set an “outperform” rating for the company in a research report on Monday, August 4th. Finally, JPMorgan Chase & Co. dropped their price objective on Avantor from $17.00 to $14.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Seven investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $15.96.
Read Our Latest Research Report on AVTR
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- What is a penny stock? A comprehensive guide
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- Quiet Period Expirations Explained
- Is Landstar the Next Big Winner in Transportation Stocks?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
